Quest PharmaTech Appoints Mr. Mark Lievonen, former President of Sanofi Pasteur Limited, to the Board of Directors
EDMONTON, ALBERTA, – Quest PharmaTech Inc. (TSX-V: QPT), a pharmaceutical company developing and commercializing products to improve the quality of life, today announced the appointment of Mr. Mark Lievonen, to the Company’s Board of Directors. Mr. Lievonen has over 30 years’ experience in the pharmaceutical industry, more recently as the President of Sanofi Pasteur Limited, the Canadian vaccine division of Sanofi, a global pharmaceutical company.
Mr. Lievonen has received many awards and honours, including his appointment to the Order of Canada in 2015. He was named a Chevalier de l'Ordre National de Mérite by the government of France in 2007, and was inducted into the Canadian Healthcare Marketing Hall of Fame in 2013.